Literature DB >> 10679921

Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer.

K Hamada1, T Kohno, M Takahashi, M Yamazaki, M Yamazaki, H Tashiro, C Sugawara, S Ohwada, Y Sekido, J D Minna, J Yokota.   

Abstract

We examined 149 lung cancer cell lines for homozygous deletions using 24 DNA markers, which were mapped and ordered in chromosome band 9p21, to define the target regions for 9p21 deletions in human lung cancer. Homozygous deletions were detected in 39 (26%) cell lines and clustered at 2 independent regions. One was the region containing the p16/CDKN2A tumor suppressor gene, and this region was deleted in 32 (21%) cell lines. The other was the region containing D9S171, which is the locus approximately 3 Mb proximal to the CDKN2A locus. This region, designated as the D9S171 region, was deleted in 18 (12%) cell lines. Seven of the 18 cell lines had identical minimum deletions of a 17,036 bp sequence located 20 kb distal to the D9S171 locus. However, such a deletion was also observed in the corresponding B-lymphoblastoid cell line from 1 of the 7 cell lines and in 5 (16%) of 32 noncancerous tissues, suggesting that the deletion was a genetic polymorphism. By considering this polymorphism, 11 (7%) cell lines still had deletions at the D9S171 region. Two NSCLC cell lines showed deletions at the D9S171 region and retentions of the CDKN2A locus. Furthermore, an NSCLC cell line showed discontinuous deletions including either the CDKN2A or D9S171 locus. Therefore, the region surrounding the D9S171 locus was defined as another target region for the 9p21 deletions. It is possible that unknown tumor suppressor gene(s) are present in this chromosomal region. Genes Chromosomes Cancer 27:308-318, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679921

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  Mutation and expression of the DCC gene in human lung cancer.

Authors:  T Kohno; T Sato; S Takakura; K Takei; K Inoue; M Nishioka; J Yokota
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

2.  MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer.

Authors:  Michiho Nishioka; Takashi Kohno; Masachika Tani; Nozomu Yanaihara; Yoshio Tomizawa; Ayaka Otsuka; Shigeru Sasaki; Keiko Kobayashi; Toshiro Niki; Arafumi Maeshima; Yoshitaka Sekido; John D Minna; Saburo Sone; Jun Yokota
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-03       Impact factor: 11.205

3.  Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer.

Authors:  Zhihong Shan; Tracy Parker; Jonathan S Wiest
Journal:  Oncogene       Date:  2004-08-26       Impact factor: 9.867

4.  A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.

Authors:  Takashi Kohno; Ayaka Otsuka; Luc Girard; Masanori Sato; Reika Iwakawa; Hideaki Ogiwara; Montse Sanchez-Cespedes; John D Minna; Jun Yokota
Journal:  Genes Chromosomes Cancer       Date:  2010-04       Impact factor: 5.006

5.  MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A.

Authors:  Lumin Wang; Jiayi Yao; Hongfei Sun; Kang He; Dongdong Tong; Tusheng Song; Chen Huang
Journal:  Oncol Lett       Date:  2016-11-23       Impact factor: 2.967

6.  Establishment of cell lines with high- and low-metastatic potential from PC-14 human lung adenocarcinoma.

Authors:  N Shindo-Okada; K Takeuchi; Y Nagamachi
Journal:  Jpn J Cancer Res       Date:  2001-02

7.  Establishment of cell lines with high and low metastatic potential from A549 human lung adenocarcinoma.

Authors:  Nobuko Shindo-Okada; Kaori Takeuchi; Beom-Seok Han; Yasuhiro Nagamachi
Journal:  Jpn J Cancer Res       Date:  2002-01

8.  TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo.

Authors:  Zhihong Shan; Abbas Shakoori; Sohrab Bodaghi; Paul Goldsmith; Jen Jin; Jonathan S Wiest
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.